| Vaccination considerations for persons with underlying medication conditions | Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents |
|---|---|
| Centers for Disease Control and Prevention |
Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations.
1| Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine | Vaccine Adverse Event Reporting System |
|---|---|
| Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States | Centers for Disease Control and Prevention |
COVID-19 vaccines vs variants — Determining how much immunity is enough.
| Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
|---|---|
| Centers for Disease Control and Prevention | COVID-19 vaccine reactions: The difference between common and allergic reactions |
Centers for Disease Control and Prevention.